This presentation seems clear that fda diagnostic aid as we all invested in is all but abandoned. The product that aims to assist gps but is not in any way diagnostic is unlikely be adopted by time poor doctors when it is merely a data source in the same way wearables provide. Medibio are not likely to commercialise at all which they’ve changed to CY end 19. Small pilots. No diagnostics. No de novo. No quality and regulatory staff. No FDA experience. With the one product they have developed listed for a possible longer term focus but not next 12 months. No burn but no product.
I think they just killed all further subscription likelihood. Goad Fidelity and Regal don’t manage my funds.
- Forums
- ASX - By Stock
- TRI
- Ann: Investor Presentation - February 2019
Ann: Investor Presentation - February 2019, page-2
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.140M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 498 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30121 | 0.020 |
5 | 577328 | 0.019 |
7 | 918500 | 0.018 |
2 | 306000 | 0.017 |
1 | 35000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 160018 | 2 |
0.023 | 185145 | 2 |
0.024 | 29166 | 1 |
0.026 | 20000 | 1 |
0.027 | 500000 | 1 |
Last trade - 07.58am 30/09/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
Day chart unavailable